• Mashup Score: 0

    Clear evidence of heavier burden of disease for patients in GOLD B, compared with GOLD A, & highlights factors assoc. with worse outcomes in GOLD A/B.

    Tweet Tweets with this article
    • Burden of #Disease in #Patients with Mild or Mild-to-Moderate #Chronic #Obstructive #Pulmonary #Disease (Global Initiative for Chronic Obstructive #Lung Disease Group A or B): A Systematic Literature Review #COPD https://t.co/w4Mrh5ndag https://t.co/ryC2fjveEO

  • Mashup Score: 0

    Comparing adherence to once-daily UMEC/VI, a long-acting muscarinic antagonist/long-acting β2-agonist and twice-daily inhaled corticosteroids in COPD

    Tweet Tweets with this article
    • Comparative #Effectiveness of #Umeclidinium/ #Vilanterol versus #Inhaled #Corticosteroid/Long-Acting β2-Agonist in #Patients with #Chronic #Obstructive #Pulmonary #Disease in a Primary Care Setting in England #COPD https://t.co/rSruqnpNPF https://t.co/28yeu3bgH7